logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HGNEC of the lung: disappointing results from irinotecan plus cisplatin

Drug combination offered no survival benefit over standard etoposide plus cisplatin.